Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.36 is 25% above its 5-year average of -4.47, near the high end of its 5-year range (-6.16–-2.40).
25.83% above its 12-month average of -4.53.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.80.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.36
EARNINGS PER SHARE (EPS) AVG TTM
-4.53
EARNINGS PER SHARE (EPS) AVG 3Y
-5.16
EARNINGS PER SHARE (EPS) AVG 5Y
-4.47
EARNINGS PER SHARE (EPS) AVG 10Y
-3.11
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+25.83%
CURRENT VS 3Y AVG
+34.88%
CURRENT VS 5Y AVG
+24.83%
CURRENT VS 10Y AVG
-7.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Intellia Therapeutics, Inc.
Market Cap
$1.71B
Earnings Per Share (EPS)
-3.36
TTM Avg
-4.53
3Y Avg
-5.16
5Y Avg
-4.47
Market Cap
$1.74B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$2.16B
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.56
3Y Avg
-1.52
5Y Avg
-1.27
Market Cap
$1.00B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$2.52B
Earnings Per Share (EPS)
-0.86
TTM Avg
-2.70
3Y Avg
-2.81
5Y Avg
-3.40
Market Cap
$2.76B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$474.59M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
Market Cap
$394.23M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | $1.71B | -3.36 | -4.53 | -5.16 | -4.47 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | -2.74 | -3.74 | -3.13 | -1.84 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -1.04 | -1.56 | -1.52 | -1.27 |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -0.99 | -3.50 | -23.24 | -16.84 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -0.86 | -2.70 | -2.81 | -3.40 |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 3.86 | 3.33 | 1.17 | 0.32 |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | -1.98 | -3.65 | -4.15 | -2.79 |
| NRC Health (NRC)vs › | $458.62M | 0.25 | 0.79 | 1.03 | 1.18 |
| Shoulder Innovations, Inc. (SI)vs › | $394.23M | -1.71 | -1.36 | -1.12 | -1.12 |
| PDS Biotechnology Corporation (PDSB)vs › | $41.86M | -0.64 | -0.89 | -1.15 | -1.02 |
Trailing EPS (TTM)
$-3.36
Forward EPS (Est.)
$-3.21
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.81 |
| 2024-12-31 | -5.25 |
| 2023-12-31 | -5.42 |
| 2022-12-31 | -6.16 |
| 2021-12-31 | -3.78 |
| 2020-12-31 | -2.40 |
| 2019-12-31 | -1.96 |
| 2018-12-31 | -1.98 |
| 2017-12-31 | -1.88 |
| 2016-12-31 | -0.91 |
| 2015-12-31 | -0.70 |
| 2014-12-31 | -1.39 |
